ITC Refuses to OK Amgen, Roche Anemia Drug Deal

The U.S. International Trade Commission finally dropped its investigation into a patent fight between Amgen and Roche over an anemia drug after their 2009 settlement but refused to approve what it said was an unusual consent order requested by the parties.
Law360